Received: from 173.45.181.97 ([173.45.181.97])
        (SquirrelMail authenticated user nancy@sleepsquares.com)
        by breakout.whspn.net with HTTP;
        Mon, 21 Feb 2011 13:16:26 -0700
Message-ID: <ea0c9dd51c63f21345dc891ac9027aec.squirrel@breakout.whspn.net>
In-Reply-To:
 <C02813C01E385A4AAF24204506C3CF9FB55F24E0@URMCMS11.urmc-sh.rochester.edu>
References: <aed068b81cdf6cd43448bdbf387b6143.squirrel@breakout.whspn.net>
    <C02813C01E385A4AAF24204506C3CF9FB55F24E0@URMCMS11.urmc-sh.rochester.edu>
Date: Mon, 21 Feb 2011 13:16:25 -0700
Subject: RE: Sleep Squares Clinical Study
From: nancy@sleepsquares.com
To: "Pigeon, Wilfred" <Wilfred_Pigeon@URMC.Rochester.edu>
User-Agent: SquirrelMail/1.4.21
MIME-Version: 1.0
Content-Type: text/plain;charset=iso-8859-1
Content-Transfer-Encoding: 8bit
X-Priority: 3 (Normal)
Importance: Normal

Hi Wil,

I just wanted to get back to you quickly on this to let you know I
received it.  There is certainly a lot to think about regarding this and I
want to discuss it more.  I am traveling all this week so I hope to get
back to you sometime in the middle of next week.  Nancy

> Thanks Nancy,  it was nice to speak with you as well (and thanks for
> contacting me). This would be fun and interesting for us to do.
>
> So here's the ugly reality.  To do a study similar to the tart cherries
> study, where we have a target of 15 completers in a crossover design,
> where each participant starts with a one week baseline, one week of
> "Supplement" A, one week 'washout', and then one week of supplment "b".
> We would have three study/office visits (1 for intake and informed
> consent; 1 after the 2 week mark, and one after the 4 week mark).
> Measures would include a host of self-report instruments and the ZEO.
>
> I see this as a 9 month process from execution of contract (which will
> itself take a couple of months becasue of our lega l dept. needing to
> review it).  2 months to finalize protocol and get IRB approval, 6 months
> to recruit and get folks through the study ad one month for data entry and
> data analysis.  I would porvidea summary report to you, which you can use
> for your own purposes and would simultaneosuly submit as an abstract
> somehwere as well as a manuscript.  Ubiversity policy is that I could not
> do interviews or say anything about the study until the results are
> presnted somehwere at a scientific meeting or it gets published.
>
> Budegt which includes:
> - salary support for me, a research coordinator and a medical director (as
> I'm a PhD , we would need an MD on board for a small 5 effort)
> - use of Zeos
> - advertising for subjects
> - payment to subjects
> - IRB fees
> - and the nasty 33% university overhead "indirect rate"
>
> comes in around $35,000.
>
> if we doff the Zeos and just go with self-report we could have only one
> study visit at study initiation and subjects could mail back their
> self-report forms, this would save ~$5,000.
>
> Might also consider doing a two group design (Sleep Square vs. Placebo)
> and having something like 12 per group as a target.  This increases sample
> size but you would only need two weeks in the study instead of four (and
> one less study visit). Costs would be in the same ballpark. If we move
> forward, I might actually try to steer you in that direction.
>
> If this is still in the ballpark for you, there are some design
> considerations to go over including:
>
> - age range of subjects (suggest 21 and over)
> - what cutoff to use for inclusion on sleep problem (just a sleep
> complaint or meeting dignositc critieria and/or other benchmark)
> - can they be on medications (the common ones being antidepressants, blood
> pressure meds, cholestoerol meds, nonsteroidal anti-inflammatories)
> - can thay have common medical/psych conditions if stable (e.g. arthritis,
> back pain, diabetes, depression, anxiety, etc etc)
>
> The balance is always that the more things you exclude the cleaner the
> sample, but the harder it is to recruit the uber healthy who's only issue
> is sleep--(since 80%+ of people with insomnia have a co-morbid condition)
> .
>
> So there ya go. Happy to discuss more via email or phone.  585-393-7918 is
> the best number to reach me at.
>
> best,
>
> Wil
>
>
>
>
>
>
>
> ________________________________________
> From: nancy@sleepsquares.com [nancy@sleepsquares.com]
> Sent: Monday, February 14, 2011 4:50 PM
> To: Pigeon, Wilfred
> Subject: Sleep Squares Clinical Study
>
> Dear Wil,
>
> It was a pleasure speaking with you today concerning a possible clinical
> study of our Sleep Squares product.  As we discussed, I am enclosing a
> list of our ingredients for your review and can send you the exact amounts
> of the herbs in the proprietary blend once a NDA is signed.
>
> If you could give me a quote on a self reporting crossover study with 15
> patients as well as a study conducted with the Zeo machine or the other
> device you had mentioned I think that would be a good starting point.
>
> Thank you for your time.
>
> Nancy Murray
> www.sleepsquares.com
> 888 725 9664 ext 118

